The latest market price of mirikizumab in 2026

Milikizumab(Mirikizumab) is a humanized monoclonal antibody, mainly used to treat immune-mediated inflammatory diseases such as ulcerative colitis(UC). It reduces the inflammatory response by specifically inhibiting the activity of IL-23, thereby alleviating the symptoms of ulcerative colitis and other related diseases. As a new type of immunotherapy drug, the research and development background and clinical effects of militizumab have attracted much attention. However, as an original drug, its pricing and launch time in the Chinese market are still unclear.

As of now, the original drug of militizumab has not been launched in China, so the specific pricing for the domestic market has not yet been announced. According to its pricing information in overseas markets, the common strength of Milizumab is 300mg/15mL per vial. Depending on the market conditions in different regions, the price of each box of Milizumab may exceed RMB 10,000. It should be noted that the price of militizumab in the international market is affected by many factors, including exchange rate fluctuations, production and distribution costs and other factors, so the price may change.

Currently, due to the short time that militizumab has been on the market worldwide, no generic drugs are available. This means that if patients purchase milizumab abroad, the price is relatively high, and there are no competitive drugs available in the domestic market. Some patients can purchase the drug through cross-border e-commerce or overseas drug purchase, but this method involves certain legal and quality risks, so patients should choose carefully.

It is worth noting that as an innovative biopharmaceutical, the price of militizumab may change in the future as market competition intensifies. As the drug is launched in many countries and regions around the world, a more transparent and reasonable price system may gradually form.

Keyword tags: Militizumab, market price, ulcerative colitis, Crohn's disease, drug pricing, generic drugs

Reference materials:https://www.drugs.com/mirikizumab.html